The Novavax vaccine had 90% efficacy against COVID-19 ≥l7 d after the second dose

Research output: Contribution to journalComment/debate

4 Scopus citations
Original languageEnglish
Pages (from-to)JC124
JournalAnnals of Internal Medicine
Volume174
Issue number11
DOIs
StatePublished - 1 Nov 2021

Cite this